Clinical CMN

Microbiology
Stay Current...
Stay Informed.

N e w s l e t t e r

CMN 40 Years of the Clinical Microbiology Newsletter

Vol. 40, No. 5
Betty Ann Forbes, PhD, D(ABMM), F(AAM)1 and Alice S. Weissfeld, PhD, D(ABMM), F(AAM),2
March 15, 2018 1
Virginia Commonwealth University Medical Center, Richmond, Virginia, 2 Microbiology Specialists
www.cmnewsletter.com
Incorporated, Houston, Texas

Abstract
I n Th is Issu e
On the occasion of our retirement as editors of the Clinical Microbiology Newsletter (Newsletter), which
35 40 Years of the Clinical is now in its 40th year, we are feeling a bit nostalgic. As such, we want to pay tribute to all the people
Microbiology Newsletter who have ensured its success over the years. We want to thank our readers, who helped to make this
Newsletter so successful, and the authors, who have contributed outstanding lead articles in clinical
41 Clinical Microbiology microbiology. Having worked together for so many years on the Newsletter — Betz Forbes for 12 years,
Q&A
Alice Weissfeld for 10 years — we were intrigued by its history. In this article, we share the Newsletter
origins, the people who have shaped it along the way, and how the Newsletter, along with the discipline
of clinical microbiology, has changed during the past 40 years.

The Beginnings ideas in the publishing industry.” He approached

Corresponding author: Alice S.
Weissfeld PhD, D(ABMM),
F(AAM), Microbiology
Specialists Incorporated,
8911 Interchange Dr.,
Houston, TX 77054. Tel.:
713-663-6888. E-mail: alice@
microbiologyspecialists.com
0196-4399/©2018 Elsevier Inc.
All rights reserved
One of the great joys of our careers has been
getting to know Dr. Josephine (Jo) Morello,
who is an icon in the field of clinical microbiol-
ogy. We interviewed Dr. Morello at her retire-
ment home in Tampa, FL. She explained that
the idea for a bimonthly newsletter came from
the esteemed Dr. Laurence R. McCarthy [1]. Dr.
McCarthy has had an illustrious career in several
fields, including clinical (hospital) and industrial
microbiology, as well as in the financial arena.
He is currently an investment banker, as well
as a clinical microbiologist. The third original
editor was Dr. Donna Blazevic, who became a
practicing attorney in Minneapolis and is now
a retired partner at Bassford Remele, a Profes-
sional Association.
After some detective work, we tracked down Dr.
McCarthy to his home in Charlottesville, VA. He
graciously agreed to share his thoughts regard-
ing the Clinical Microbiology Newsletter and clini-
cal microbiology.
He explained that, back in 1978, John Lawrence
was asked to develop a Medical Book Division by
his employers, G.K. Hall Publishers. John was
“just a great guy who was always pursuing new
Dr. McCarthy at the University of North Caro-
lina, Chapel Hill, and Dr. Morello, who was at
the University of Chicago, to create a newsletter
covering issues in clinical microbiology, which
was a totally new idea in the scientific publish-
ing industry. They were asked to make the arti-
cles timely and brief, and to target the working
(bench) clinical microbiology audience. These
concepts — or as Dr. McCarthy describes them,
“a formula that had the right size and right feel”
— remain in place 40 years later. While other
newsletters have come and gone, this original
formula has continued to work well, providing
articles on new diagnostic techniques and surveys
of how readers handle blood cultures, as well as
editorials questioning common procedures and
suggesting new ones (http://www.cmnewsletter.
com/content/aims).
As editors of the Newsletter have retired over the
years, they have been replaced by other stars of
the microbiology world, (see Table 1). Dr. Paul
Granato holds the longest official tenure for the
Newsletter; because of his longevity, editing skills,
and ability to solicit timely and provocative arti-
cles from outstanding authors, Dr. Granato has

Clinical Microbiology Newsletter 40:5,2018 | ©2018 Elsevier 35

played a key role in the Newsletter’s success. We have no doubt
that Dr. Donna Wolk and Dr. Elizabeth Marlowe and our new-
est editors, Dr. Christopher Doern and Dr. Carey-Ann Burnham,
will carry on the Newsletter’s traditions. It is curious that three key
Newsletter editors — namely Dr. McCarthy, Jo Morello, and Paul
Granato, were all post-doctoral fellows in the clinical microbiology
laboratory of the eminent clinical microbiologist, Dr. Paul Ellner.
Newsletter history is uncanny, as John Lawrence, the husband of yet
another eminent clinical mycologist, Dr. Davise Larone, moved
to Elsevier, and it was after only a short period that the Newsletter
followed him to Elsevier, as well!
The Goings-On Behind the Scenes
So, what happens prior to each Newsletter? The editors meet annu-
ally, with two primary items on the agenda:
• To discuss the status of all solicited lead articles, including
whether alternate authors need to be brought in on topics of
critical importance and;
• Topropose at least 10 new topics, with corresponding authors,
for consideration as lead articles for the upcoming year. These
proposed topics often spark lively discussion!
Of note, the Newsletter also considers unsolicited articles.
Once an article is received by an editor, the manuscript is reviewed
for its scientific content and edited for clarity by all the editors.
During the last 10 years, Elsevier assigned oversight of the News-
letter to executive publishers from its health and medical sciences
division. One such executive publisher, Fiona Macnab, has been
at the helm on behalf of the Newsletter for the last five years, and
has played a critical role in its continued success. Through her
oversight, publishing skills, knowledge of the publishing industry,
and her understanding of the audience for Elsevier publications,
Ms. Macnab has been instrumental in bringing the Newsletter to
Table 1. Clinical Microbiology Newsletter editors: 1979 to present
Editor Tenure
Donna Blazevic 1979-1983
Laurence R. McCarthy 1979-1984
Josephine A. Morello 1979-2006
Sally Jo Rubin 1983-1985
Paul A. Granato 1985-present
Ronald Zabransky 1985-2004
Marie B. Coyle 1986-1987
Mary Jane Ferraro 1988-2011
Betty A. Forbes 2005-2017
Alice S. Weissfeld 2007-2017
Donna Wolk 2012-present
Elizabeth A. Marlowe 2016-present
Christopher Doern 2018-present
Carey-Ann Burnham 2018-present
36 Clinical Microbiology Newsletter 40:5,2018 | ©2018 Elsevier
a larger worldwide audience. Moreover, her skills have ensured
accessibility to and awareness of our publication.
Other critical contributors to the Newsletter are its production
editor, Jim Wojno, a guiding force for 20 years, and its copy edi-
tor, Elizabeth McGillicuddy, who has been with the Newsletter
for 16 years. The publishing schedule is a demanding one, with
new lead articles published every two weeks, year in and year out.
Both are masters of their respective fields and handle their jobs
with perfection and aplomb. Because of their skills, the quality of
the Newsletter articles maintains its high standards.
Change of Scope Over the Last Decade
Over the years, the Clinical Microbiology Newsletter editors have
prided themselves on the cutting-edge articles they solicit. The
world-wide presence of microorganisms that cause the same ill-
nesses and the same challenges for laboratory diagnostics the world
over has given the Newsletter a global readership. Table 2 lists the
24 topics for lead articles in Volume 1 from 1979, while Table 3
shows the lead articles in Volume 39 from 2017. Josephine Morello
wrote a superb review of the Newsletter’s first 30 years [2]. Writ-
ing a “lookback”/historical perspective type of article opened the
window, so to speak, for Weissfeld and Forbes to pause and reflect
about the various topics of lead articles written by experts in our
field. Thus, we would like to briefly share some of our thoughts
regarding our discipline within the context of subject matter pre-
sented in the and we’d like to follow up with a similar review of
the following ten years, to reflect on the variety of topics of lead
articles our experts in our field have written about.
Our field
One of the appeals of the Newsletter is the format: it is the “Reader’s
Digest for microbiology,” providing an easy read on relevant topics,
which allows readers to stay current. To illustrate, newly emerging
infectious agents, such as Cryptococcus gattii, Candida auris, Asper-
gillus calidoustus, Streptococcus pseudopneumoniae, and Tritrichomonas
species, were featured in Newsletter lead articles.
Content innovation and online accessibility
Technology continues to evolve for the Newsletter and clinical
microbiologists. The Newsletter’s online presence continues to be
refined and updated. Authors can now add AudioSlides to their
article, which is an innovation valuable to both the author and
reader. They can measure the impact of their article through tools
such as PlumX Metrics, which are available at article level at www.
cmnewsletter.com, in addition to monitoring the impact of the
Newsletter via CiteScore. Finally, Social media such as Facebook
and Twitter plays a prominent role in increasing the visibility of
the Newsletter.
The “then and now” and the future
Reflecting on the last decade of Newsletter topics, one is struck by
the common threads that have been carried over from the News-
letter’s first 30 years. Clinical microbiologists, by virtue of the pro-
fession, must be current with not only understanding the newest
mechanisms of antimicrobial resistance that organisms rapidly
acquire, but the challenges associated with detecting resistance in
 Issue Lead article Author(s) Editorial Author Other
1 Enzyme-linked immunosorbent assays: E.H. Gerlach Vaccination against pneumococcus G. Scott Giebink Questions and answers; case report on Clostridium
ELISA sartagoformum in a fever of unknown origin
2 Antibiotic dilution-susceptibility tests Laurence R. McCarthy Certification of laboratory R.J. Zabransky Case report on Erysipelothrix rhusiopathiae endocarditis;
personnel in microbiology Autoclavable bag caution
3 Antimicrobial susceptibility testing J. Kenneth McClatchy Proficiency testing in microbiology Raymond C. Bartlett Case report on Streptococcus sanguis II in endocarditis
relapse; questions and answers; workshops and meetings;
new tests (porphyrin production for Haemophilus spp.)
4 Yeast identification methods Billy H. Cooper Proficiency testing — is it Charles W. Griffin, III Letters to the editor; questions and answers
worthwhile? Roger N. Taylor
5 Serodiagnosis of histoplasmosis, Michael R. McGinnis NCCLS and voluntary consensus Terry J. Fadem Case report on Pseudomonas testosterone pyarthrosis and
blastomycosis, and coccidioidomycosis standards septicemia; abstracts of recent literature
6 Antimicrobial susceptibility testing of Vera L. Sutter Identification of anaerobic bacteria: Stephen D. Allen Case report on polymicrobial meningitis; workshops and
anaerobic bacteria how far to go meetings; abstracts of recent literature
7 Current status of laboratory diagnosis William B. Cherry CLIA in 1979: implications for Russell J. Eilers Abstract of recent literature; recent CDC publications;
of Legionnaires’ disease the clinical laboratory survey of sputum culture methods
8 Laboratory diagnosis of amebiasis Dorothy M. Melvin Why bother with the clinical Henry M. Balfour, Jr. H2S-positive E. coli — where are you?; case report on
virology laboratory? Mycobacterium fortuitum peritonitis; letters to the editor
9 Pathogenesis and identification of Hazel W. Wilkinson Should clinical microbiology Stuart Levin Case report on neonatal herpesvirus infection
streptococci keep up with taxonomy?
10 Chlamydia trachomatis infections Margaret A. Tipple Should clinical microbiology J. J. Farmer, III Case report on Pseudomonas putrefaciens septicemia;
Evelyn M. Saxon keep up with taxonomy? — Yes new test:antibody-coated bacteria test for localization of
Marc O. Beem urinary tract infections; questions and answers
11 Escherichia coli diarrhea Herbert L. DuPont The laboratory workload John Truell Case report on vaginal colonization by genus Mucor;
recording method new NCCLS standard; workshops and meetings
12 Automation in clinical microbiology Josephine A. Morello The future of automation in Eileen L. Randall Case report on Listeria monocytogenes meningitis;
Michael H. Graves microbiology letters to the editor
Table 2. Contents of Clinical Microbiology Newsletter, volume 1, 1979

13 Campylobacter fetus infections Donna J. Blazevic Replicator methodology Peter C. Fuchs Case report on Neisseria sicca prosthetic valve endocarditis;
abstracts of recent literature; recent CDC publications
14 Results of the sputum questionnaire The editors Value of commercial kits for Henry D. Isenberg New NCCLS standards; abstracts of recent literature
bacterial identification
15 Aerobic actinomycetes and the Philip A. Tisdall Susceptibility testing of the newer George W. Counts Case report on importance of appropriate fungal
clinical microbiology laboratory Glenn D. Roberts cephalosporins in the clinical Fritz D. Schoenknecht serology for chronic pulmonary sporotrichosis
microbiology laboratory
16 Polymorphonuclear leukocyte Harry R. Hill Doctoral-level certification for Erwin Neter Case report on three patients with CDC Enteric
function tests medical laboratory immunologists Group 8
17 Update on antibiotics Dale N. Gerding Mycobacteriological identification; Lawrence G. Wayne New test: acridine orange stain
How much? How far?
18 Serum dilution tests for determination Evelyn Busch Continuing education Thomas L. Gavan Urine questionnaire; case report on Salmonella typhi
of antibacterial activity Donna J. Blazevic septicemia; workshops and meetings
19 Brucellosis E. D. Renner The importance of cost accounting Paul D. Ellner Case report on brucellosis; questions and answers
in the laboratory
20 Nontuberculous mycobacteria Robert C. Good Use and abuse of the Gram-stained John A. Washington II Case report on multidrug-resistant mycobacterium;
smear letters to the editor
21 Viral hepatitis update Michael T. Osterholm Dehumanizing the computer Lawrence J. Kunz Case report on Microsporum racemosum as a zoophilic
dermatophytosis; letters to the editor
22 Results of the urine questionnaire The editors Should clinical microbiology be Albert Balows Letters to the editor
standardized?
23 R-plasmids and the epidemiology of James J. Plorde Perils and pitfalls of national Joseph L. Staneck Case report on Prototheca as a pathogen; new NCCLS
nosocomial infections standards for clinical microbiology standards; proposed HEW personnel requirements

Clinical Microbiology Newsletter 40:5,2018 | ©2018 Elsevier

24 What’s new in gonorrhea Josephine A. Morello On birthing a newsletter The editors Case report: Yersinia enterocolitica bacteremia; ­
workshops and meetings

37
Table 3. Contents of Clinical Microbiology Newsletter, Volume 39, 2017

Issue Lead Article Author(s) Other Author

1 Streptococcus bovis: 100 Years of an Intriguing Juan Corredoira Clinical microbiology Q & A Christopher Doern
Pathogen Ramón Rabuñal Carey-Ann Burnham
Maria Pilar Alonso
2 Postpartum Streptococcus pyogenes Joseph David Cooper Case Report on Justin Schmetterer
Outbreak in the Labor and Delivery Unit of a Surya Ram Cooper Lactococcus garvieae: Impact of Karissa Culbreath
Quaternary Referral Center: a Case Series and Donna M. Wolk Matrix-Assisted Laser Desorption Austin Ballew
Review of the Literature Ann Marie Tice Ionization – Time of Flight Mass Christine Boehringer
Tamara F. Persing Spectrometry Identification on Clinical Joseph Gorvetzian
Lisa Marie Esolen Care in a Case of Cholecystitis and Nancy Jordan
Bacteremia
3 Listeria monocytogenes Contamination of Ice Alice S. Weissfeld Disseminated Nocardia farcinica Zeti Norfidiyati Ayub
Cream: a Rare Event That Occurred Twice in Nehemiah Landes Infection in a Patient with Steroid- Habsah Hasan
the Last Two Years Hannah Livesay dependent Autoimmune Hemolytic Mohd Zulfakar Mazlan
Ernest Trevino Anemia: Case Report and Literature Alwi Muhd Besari
Review
4 Come in Out of the Cold: Alternatives to Erica Isaacs
Freezing for Microbial Biorepositories Monika Schmelz
5 “Did I Hear You Correctly? The Organism Betty A. Forbes
Identified Was Corynebacterium diphtheriae?”
6 Mycobacterium chimaera: Coming out Fran Schaeffer Strongyloides stercoralis Rebecca Rawl
of Nowhere to Dominate 2016 Infection Brooks Kennedy Hyperinfection Causing Abdominal Linda Matthews
Prevention Discussions Nehemiah Landes Pain and Hypoxia Robert L. Sautter
Ernest Trevino Martin Scobey
Paula Vance
Alice S. Weissfeld
7 Self-Collected Specimens for Infectious Fred C. Tenover
Disease Testing Ellen Jo Baron
Charlotte A. Gaydos
8 Statistics for Method Verification of Donna M. Wolk
Qualitative Assays in Clinical Microbiology
9 Trends in Laboratory Utilization Sarah B. Riley
10 The Multipurpose Tool of Social Media: Julie M. Wolf Multidrug-Resistant Mycobacterium Zeti Norfidiyati Ayub
Applications for Scientists, Science tuberculosis: Issues and Controversies Habsah Hasan
Communicators, and Educators Siti Suraiya
Mohd Zulfakar Mazlan
Alwi Muhd Besari
11 Optimal use of Rapid Diagnostics in Infection Mary Elizabeth Sexton
Control and Prevention Jesse T. Jacob
12 The Potential Role of Polymerase Chain Nicole L. Samies
Reaction in Diagnosis of Neonatal Herpes Swathi M. Gowtham
Simplex Virus Infection: Is Viral Culture
Outdated?
13 Candida auris for the Clinical Microbiology Shawn R. Lockhart Chryseobacterium indologenes Urinary Pallavi Tripathi
Laboratory: Not Your Grandfather’s Candida Elizabeth L. Berkow Tract Infection: a Case Report Anjani Singh
Species Nancy Chow Vandana Lal
Rory M. Welsh
14 Best Practices in Diagnosing Respiratory Viral Abraham J. Qavi
Disease Neil W. Anderson
15 Right-Sizing Technology in the Era of Eszter Deak
Consumer-Driven Health Care Elizabeth M. Marlowe
16 Rapid Molecular Panels: What Is in the Best Kaede V. Sullivan Lactococcus garviae Prosthetic Mitral Ewout Landeloos
Interest of the Patient? A Review of Patient Valve Endocarditis: a Case Report and Guy Van Camp
Outcome Studies for Multiplex Panels Used Literature Review Hans De Beenhouwer
in Bloodstream, Respiratory, and Neurological
Infections
17 Clinical Impact of Multiplex Syndromic April N. Abbott
Panels in the Diagnosis of Bloodstream, Ferric C. Fang
Gastrointestinal, Respiratory, and Central
Nervous System Infections
18 The Emergence of Streptococcus anginosus Emily M. Hill Campylobacter fetus Pleuropneumonia Boris Lukšić
Group as a Cystic Fibrosis Pathogen and Bacteremia in an Adult Svjetlana Karabuva
Immunocompetent Patient Marina Radić
Jakica Karanović
Bruno Lukšić

38 Clinical Microbiology Newsletter 40:5,2018 | ©2018 Elsevier

Table 3 (coninued). Contents of Clinical Microbiology Newsletter, Volume 39, 2017
Issue Lead Article Author(s)
19 Point-of-Care Testing for Group A Jennifer Woo
Streptococcus Infection and Influenza Valerie Arboleda
Omai B. Garner
20 The Changing Epidemiology and Diagnosis Bridget M. Barker
of Valley Fever
21 Laboratory Diagnosis of Non-Tuberculous Kara J. Levinson
Mycobacterium Infections in Bronchiectasis Peter H. Gilligan
Patients: Issues and Controversies
22 Lab Tests Online: a Ground-Breaking and Dominique Smith
Enduring Health Resource
23 Promoting Good Laboratory Practices for Nancy Anderson
Waived Infectious Disease and Provider- Heather Stang
Performed Microscopy Testing
24 Fastidious and Furious: Reporting Antimicro- D. Jane Hata
bial Susceptibility Testing for Fastidious or
Infrequently Isolated Bacteria
the laboratory, as well as new antibiotics introduced into clinical
practice. For example, notable topics have included daptomycin
[3], with its requirement for calcium supplementation to ensure
reliable susceptibility results; ceftaroline [4], with its new niche
for staphylococcal infections, especially methicillin-resistant
Staphylococcus aureus; the testing of Mycobacterium tuberculosis iso-
lates that are multidrug resistant or extensively drug resistant [5];
and remaining challenges with finding a reliable method to test
susceptibility to the polymyxin antimicrobials [6], to name a few.
Another common thread is the need for updates on taxonomy, such
as Nocardia species [7]; updates from oversight organizations for
the profession (CLIA, CAP, the FDA, and CLSI), coupled with the
introduction or changing of laboratory policies and procedures,
such as the individualized quality control plan (IQCP) in microbi-
ology [8]; verification and validation of clinical microbiology tests
[9]; and laboratory practices for waived infectious disease testing
[10]. The Newsletter has continued to “help identify, define, and
provide guidance on the issues most relevant to clinical microbi-
ology laboratorians and infectious disease practitioners” [2]. Also,
the Newsletter has provided information about clinical microbiol-
ogy groups who provide oversight and/or guidance, such as the
American Society for Microbiology (ASM) [11], CDC’s Clinical
Laboratory Improvement Advisory Committee (CLIAC) [12] and
ASM’s Public and Scientific Affairs board [13].
Another common thread is the hunger for information about new
methods for identification of microorganisms. One need only
consider the development of mass spectrometry methods, from
their emergence early in the last decade to now, when matrix-
assisted laser desorption ionization–time of flight mass spectrom-
etry (MALDI-TOF MS) has become mainstream in large clinical
Other Author
Frequent Relapse of Plasmodium vivax Zeti Norfidiyati Ayub
Infection: Case Report and Literature Habsah Hasan
Review Zeehaida Mohamed
Alwi Muhd Besari
Mohd Zulfakar Mazlan
Fatal Wohlfahrtiimonas Siti Suraiya
chitiniclastica Bacteremia in an Nik Zuraina
Immunocompromised Patient Fadzhilah Ahmad
Zaidah Abdul Rahman
Concomitant Mycoplasma pneumoniae Zeti Norfidiyati Ayub,
and Influenza B Virus Pneumonia in a Azian Harun
Child without Evidence of Influenza A Chan Yean
(H5N1) Virus Infection Alwi Muhd Besari
Mimi Azliha Abu Bakar
microbiology laboratories [14-17]. In addition, the repertoire of
commercial molecular methods made available to the clinical labo-
ratories has expanded at a staggering pace - from a single patho-
gen to syndromic panels with smaller and smaller devices. These
advances will continue at lightning speed.
Another common thread is the continued requirement to under-
stand and diagnose various infections, from syphilis [18] to pros-
thetic joint infections [19], encephalitis [20], tick-borne infections
[21], bacterial sepsis [22], infections in cystic fibrosis patients
[23,24], and middle ear infections [25]. And finally, the close rela-
tionship between the control and prevention of community- and
hospital-acquired infections, with the laboratory playing a role not
only in the diagnosis of such infections [26,27], but in antimicro-
bial stewardship programs [28].
Looking forward to the next ten years, one sees an increasing role
for “omics” in the diagnosis of infectious diseases in the human
host, from proteomics and metabolomics to genomics and cul-
tureomics. As bioinformatics programs and next-generation
sequencing instruments become more routine and thus easier to
use, this approach to diagnosing infections has the potential to
“up end” clinical microbiology laboratory practice and knowledge
bases; one need only consider how the dogma that urine is ster-
ile is falling from favor. More, newer, smaller, and more portable
molecular diagnostic systems will become mainstream and, as
such, may become point-of-care diagnostics. We have seen amaz-
ing developments during our 40 years of microbiology practice,
and we are sure that the excitement and wonder of this incredible
discipline will continue, and that the Newsletter will follow these
developments in a timely, relevant, and credible fashion!
Clinical Microbiology Newsletter 40:5,2018 | ©2018 Elsevier 39
Miscellaneous
New approaches and features continue to be discussed among
Newsletter personnel. In 2017, a new feature called Clinical Micro-
biology Q and A’s was added. This feature, patterned after the
Medical Microbiology Question of the Day website, tests their
knowledge of practicing clinical microbiologists, not only in clini-
cal microbiology, but infectious diseases. Significantly, the Newslet-
ter partnered with a number of societies and regional microbiology
branches to offer preferential subscription rates to their members.
All the editors, past and present, are committed to ensuring the
Newsletter not only serves as a go-to source for individuals who
practice clinical microbiology, but is widely available to those who
practice the profession of clinical microbilogy, as well.
Summary
Forty years of the Clinical Microbiology Newsletter — the measure of
our lifetime as clinical microbiologists! The Clinical Microbiology
Newsletter is as strong as ever. As microbiologists, we often find
ourselves in the role of Sherlock Holmes investigating causes of
infections and outbreaks. The need for microbiological knowledge
remains vital. Keep subscribing. Our field is changing rapidly!
References
[1] Blazevic DJ, McCarthy LR, Morello JA. On birthing a newsletter.
Clin Microbiol Newsl 1979;1:5-6.
[2] Morello JA. Clinical Microbiology Newsletter at age 30 — history
and evolution. Clin Microbiol Newsl 2008;30:1-5.
[3] Koeth LM, Thorne GM. Daptomycin in vitro susceptibility meth-
odology: a review of methods, including determination of calcium
in testing media. Clin Microbiol Newsl 2010;32:161-9.
[4] Yee C, Biek D, Krause K, Williams G. Ceftaroline: a cephalosporin
with anti-MRSA activity. Clin Microbiol Newsl 2011;33:161-9.
[5] Baron EJ. The many facets of drug susceptibility testing for Myco-
bacterium tuberculosis. Clin Micrbiol Newsl 2013;36:73-7.
[6] Jerke KH, Lee MJ, Humphries RM. Polymyxin susceptibility testing:
a cold case reopened. Clin Microbiol Newsl 2016;38:69-77.
[7] Brown-Elliott BA, Conville P, Wallace RJ. Current status of Nocardia
taxonomy and recommended identification methods. Clin Microbiol
Newsl 2015;37:25-32.
[8] Anderson N. The individualized quality control plan — coming soon
to clinical microbiology laboratories everywhere! Clin Microbiol
Newsl 2015;37:177-85.
[9] Tibbetts RF. Verification and validation of tests used in the clinical
microbiology laboratory. Clin Microbiol Newsl 2015;37:153-60.
40 Clinical Microbiology Newsletter 40:5,2018 | ©2018 Elsevier
[10] Anderson N, Stang H. Promoting good laboratory practices for
waived infectious disease and provider-performed microscopy testing.
Clin Microbiol Newsl 2017;39:183-8.
[11] Sharp SE, Enquist LW. What have we done for you lately? The
role of the American Society for Microbiology in advancing clinical
microbiology. Clin Microbiol Newsl 2016;38:95-100.
[12] Anderson N, Bosse DC, Weissfeld AS. The impact of clinical
laboratory improvement advisory committee recommendations on
microbiology laboratories. Clin Microbiol Newsl 2009;31:129-36.
[13] Walker KE, O’Brien ME. The policy of microbiology. Clin Micro-
biol Newsl 2015;37:199-202.
[14] Theel ES. Matrix-assisted laser desorption ionization-time of flight
mass spectrometry for the identification of bacterial and fungal iso-
lates. Clin Microbiol Newsl 2013;35:155-61.
[15] Dekker JP, Branda JA. MALDI-TOF mass spectrometry in the clini-
cal microbiology laboratory. Clin Microbiol Newsl 2011;33:87-93.
[16] Khot PD , Fisher MA. Mass spectrometry in the clinical micro-
biology laboratory, part II: MALDI-TOF. Clin Microbiol Newsl
2012;34:143-7.
[17] Doern CD. Charting uncharted territory: a review of the verifica-
tion and implementation process for matrix-assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF MS) for
organism identification. Clin Microbiol Newsl 2013;35:69-78.
[18] Soreng K, Levy R, Fakile Y. Serologic testing for syphilis: ben-
efits and challenges of a reverse algorithm. Clin Microbiol Newsl
2014;36:195-202.
[19] Gomez E, Patel R. Laboratory diagnosis of prosthetic joint infection,
part I and II. Clin Microbiol Newsl 2011;33:55-60, 63-70.
[20] Reznicek JE, Bloch KC. Diagnostic testing for encephalitis, part I
and II. Clin Microbiol Newsl 2010;32:17-23, 25-31.
[21] Magnarellli LA. Global importance of ticks and associated infectious
disease agents. Clin Microbiol Newsl 2009;31:33-7.
[22] Soreng K, Levy R. Procalcitonin: an emerging biomarker of bacterial
sepsis. Clin Microbiol Newsl 2011;33:171-8.
[23] Kiska DL, Riddell SW. Practical laboratory aspects of cystic fibrosis
microbiology, part I and II. Clin Microbiol Newsl 2012;34:27-31,
35-41.
[24] Hill EM. The emergence of Streptococcus anginosis group as a cystic
fibrosis pathogen. Clin Microbiol Newsl 2017;39:143-7.
[25] Wolk DM. Microbiology of middle ear infections: do you hear what
I hear? Clin Microbiol Newsl 2016;38:87-93.
[26] Thompson K. Clostridium difficile: strategies for environmental con-
trol. Clin Microbiol Newsl 2012;34:193-6.
[27] Barenfanger J, Benté J, Havener G. Optimal performance for clinical
microbiologists and their interaction with infection control staff. Clin
Microbiol Newsl 2009;31:9-15.
[28] Wang JS, Bearman G, Edmond M, Stevens MP. Guarding the goods:
an introduction to antimicrobial stewardship. Clin Microbiol Newsl
2012;34:93-7.